“Design and docking of novel series of hybrid xanthones as anti-cancer agent to target human DNA topoisomerase 2-alpha”, Bangladesh J Pharmacol, vol. 9, no. 2, pp. 208–217, May 2014, doi: 10.3329/bjp.v9i2.18180.